Brief: Atara Biotherapeutics Announces Fourth Quarter And Full Year 2022 Financial Results

Atara Biotherapeutics

08/02/2023 21:08

Feb 8 (Reuters) - Atara Biotherapeutics Inc  ATRA.O :
    * ATARA BIOTHERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL
YEAR
2022 FINANCIAL RESULTS AND OPERATIONAL PROGRESS
    * ATA188 PHASE 2 EMBOLD STUDY PRIMARY DATA READOUT ON-TRACK
FOR
OCTOBER 2023
    * EBVALLO EU LAUNCH ACTIVITIES LED BY PIERRE FABRE TO
COMMENCE IN
Q1 2023
    * IND FOR ATA3219 IS ANTICIPATED FOR Q2 2023
    * CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS AS OF
DECEMBER
31, 2022 TOTALED $242.8 MILLION
    * QTRLY BASIC AND DILUTED NET LOSS PER COMMON SHARE $0.72
    * Q4 EARNINGS PER SHARE VIEW $-0.51, REVENUE VIEW $39.7
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nBw56HPWCa 
Further company coverage:  ATRA.O 
 ((Reuters.Briefs@thomsonreuters.com))